Increased levels of HMGB1 in the sputum or bronchoalveolar lavage fluid of asthma, chronic obstructive pulmonary disease (COPD), systemic sclerosis and idiopathic pulmonary fibrosis patients are associated with disease severity 4–8. Here, HMGB1 is linked to asthma.